United States · FDA National Drug Code directory
Rivastigmine Transdermal System
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63629-2064_e630022b-cdf9-4d31-93b6-13bc245df7c4
- Product NDC
- 63629-2064
- Form
- PATCH, EXTENDED RELEASE
- Composition / generic term
- Rivastigmine
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20191219
- Source listing expiry
- 20261231
Source-listed ingredients
- RIVASTIGMINE — 13.3 mg/24h
These values do not establish equivalence or a dose recommendation.
Packages
- 30 POUCH in 1 CARTON (63629-2064-1) / 1 PATCH in 1 POUCH (63629-2064-2) / 24 h in 1 PATCH · 63629-2064-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →